Merck Announces New Data from KEYNOTE-028 Trial Evaluating KEYTRUDA Across Range of Cancer Types, Presented at 2015 ECC
September 27, 2015 at 07:54 AM EDT
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new findings from the ...